(MariTide) Boehringer Ingelheim GmbH Zealand Pharma A/S Hanmi Pharmaceutical Co., Ltd
Pin addition, perform high-throughput screening of receptor agonists or antagonists and reliably determine corresponding EC50 or IC50 values
Escalate in stages, by adding 0.5-1 mg a week, until the final and maintenance dose is reached (12 mg in the New England Journal trial)
In the founding research, Ipamorelin raised GH with little to no rise in cortisol or prolactin unlike older GH secretagogues
This personalized approach often yields faster, more sustainable results than starting therapy while lactating
It helps support red blood cell production and is useful in managing conditions tied to poor nutrient absorption, anemia, or gastrointestinal disease